The Coronary Drug Project: Initial Findings Leading to Modifications of Its Research Protocol

JAMA: The Journal of the American Medical Association

Volumn 214, Issue 7, 1970, Pages 1303-1313

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; CONJUGATED ESTROGEN; DEXTROTHYROXINE; HYPOCHOLESTEROLEMIC AGENT; NICOTINIC ACID DERIVATIVE; PLACEBO; PROPIONIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MALE; MORTALITY; THROMBOPHLEBITIS; TIME;

ADULT; ANTICHOLESTEREMIC AGENTS; CLINICAL TRIALS; CLOFIBRATE; COMPARATIVE STUDY; CORONARY DISEASE; DEXTROTHYROXINE; ELECTROCARDIOGRAPHY; ESTROGENS, CONJUGATED; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; NICOTINIC ACIDS; PLACEBOS; PROPIONATES; PULMONARY EMBOLISM; STATISTICS; THROMBOPHLEBITIS; TIME FACTORS;

EID: 0014952170     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1970.03180070069012     Document Type: Article

References (24)

1. Stamler J: Lectures on Preventive Cardiology, New York, Grune & Stratton Inc, 1967.
2. Little JA, Shanoff HM, Roe RD, et al: Studies of male survivors of myocardial infarction: IV. Serum lipids and five-year survival. Circulation 31:854-862, 1965.
3. Frank CW, Weinblatt E, Shapiro S: Prognostic implications of serum cholesterol in coronary heart disease, in Jones RJ, (ed): Atherosclerosis: Second International Symposium. New York, Springer-Verlag to be published.
4. Leren P: Effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. Acta Med Scand, suppl 466, pp 1-90 1966.
5. Control of hyperlipidemia: IV. Progress in drug trials of secondary prevention, with particular reference to the coronary drug project, Coronary Drug Project Research Group, in Jones RJ (ed): Atherosclerosis: Second International Symposium. New York, Springer-Verlag, to be published.
6. Heart drug project yields good results. JAMA 213:954-956, 1970.
7. Stamler J, Pick R, Katz LN, et al: Effectiveness of estrogens for therapy of myocardial infarction in middle-aged men. JAMA 183:632-638, 1963.
8. Stamler J, Lewis LA, Page IH, et al: Estrogens and androgens in the treatment of hyperlipidemia, in Moyer JH, Brest AN (eds): Cardiovascular Drug Therapy, New York, Grune & Stratton Inc, 1965, pp 353363.
9. Oliver MF, Boyd GS: Influence of reduction of serum lipids on prognosis of corcnary heart disease: A five-year study using estrogen. Lancet 2:499-505, 1961.
10. Marmorston J, Moore FJ, Hopkins CE, et al: Clinical studies of long-term estrogen therapy in men with myocardial infarction. Proc Soc Exp Biol Med 110:400-408, 1962.
11. Coronary drug project enters enrollment phase. JAMA 200, June 19, 1967, adv pp 37-38.
12. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis, ed 6, Criteria Committee of New York Heart Association. Boston, Little, Brown & Co., 1964.
13. Blackburn H, Keys A, Simonson E, et al: The electrocardiogram in population studies: A classification system. Circulation 21:1160-1174, 1960.
14. Rose G, Blackburn H: Cardiovascular Survey Methods, monograph 56, World Health Organization, Geneva, 1968.
15. Cornfield J: Bayesian outlook and its application. Biometrics 25:617-657, 1969.
16. Lown B, Klein MD, Hershberg PI: Coronary and precoronary care. Amer J Med 46:705-724, 1969.
17. Robinson RW, Higano N, Cohen WD: Long-term effects of high dosage estrogen therapy in men with coronary heart disease. J Chron Dis 16:155-161, 1963.
18. Treatment and survival of patients with cancer of the prostate, Veterans Administration Cooperative Urological Research Group. Surg Gynec Obstet 124: 1011-1017, 1967.
19. An evaluation of estrogenic substances in the treatment of cerebral vascular disease: A report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section. Circulation 33 & 34 (suppl 2): II-3-II-9, 1966.
20. McDowell F, Louis S, McDevitt E: A clinical trial of premarin in cerebrovascular disease. J Chron Dis 20:679-684, 1967.
21. Inman WHW, Vessey MP, Westerholm B: et al: Thromboembolic disease and the steroidal content of oral contraceptives: A report to the Committee on Safety of Drugs. Brit Med J 2:203-209, 1970.
22. Oliver MF: Oral contraceptives and myocardial infarction. Brit Med J 2:210-213, 1970.
23. Oestrogens and thromboembolism, editorial. Brit Med J 2:189-190, 1970.
24. Bailar JC III, Byar DP: (Veterans Administration Cooperative Urological Research Group): Estrogen treatment for cancer of the prostate: Early results with three doses of diethylstilbesterol and placebo. Cancer 26:257-261, 1970.